|
Variables
|
adjusted OR for CIN 2+ (95%CI): model 1
|
P-value
|
adjusted OR for CIN 2+ (95%CI): model 2
|
P-value
|
|---|
|
Age 30 and above
|
0.9 (0.3–2.3)
|
0.8
| | |
|
pHR and HR co-infections prevalence
|
1.6 (0.6–4.5)
|
0.4
| | |
|
CD4 count < 200
|
2.2 (0.8–5.8)
|
0.2
| | |
|
HPV 16
|
1.3 (0.5–3.6)
|
0.6
|
1.2 (0.4–3.5)
|
0.7
|
|
HPV 18
|
1.2 (0.3–4.2)
|
0.8
|
1.1 (0.3–3.9)
|
0.9
|
|
HPV 31
|
5.0 (1.1–21.6)
|
0.03
|
4.9 (1.03–22.5)
|
0.05
|
|
HPV 33
|
3.0 (0.8–11.5)
|
0.1
|
2.9 (0.7–11.1)
|
0.1
|
|
HPV 35
|
1.6 (0.5–4.4)
|
0.5
|
1.4 (0.4–5.0)
|
0.6
|
|
HPV 39
|
2.6 (0.6–12.3)
|
0.2
|
2.4 (0.5–11.6)
|
0.3
|
|
HPV 51
|
1.7 (0.4–6.4)
|
0.4
|
1.6 (0.4–6.1)
|
0.5
|
|
HPV 52
|
1.6 (0.5–5.1)
|
0.5
|
1.3 (0.4–4.7)
|
0.6
|
|
HPV 53
|
0.6 (0.2–2.0)
|
0.4
|
0.5 (0.1–1.7)
|
0.3
|
|
HPV 56
|
1.6 (0.5–5.6)
|
0.4
|
1.4 (0.4–5.2)
|
0.6
|
|
HPV 58
|
1.0 (0.3–4.0)
|
1.0
|
1.0 (0.3–3.5)
|
1.0
|
|
HPV 66
|
0.2 (0.04–1.0)
|
0.06
|
0.2 (0.03–0.9)
|
0.04
|
|
HPV 68
|
0.5 (0.05–5.4)
|
0.4
|
0.2 (0.04–4.5)
|
0.5
|
- Model 1: adjusted for CD4 count, age
- Model 2: adjusted for CD4 count, age, and pHR and HR HPV coinfections
- P-value from Likelihood Ratio Test
